MarketPulse
I

$IBB

3 articles found
0 positive
0 negative
3 neutral
The Motley FoolThe Motley Fool··Andy Gould

Swiss Biotech Fund Doubles Down on Relay With $6M Stake Bet

Swiss biotech fund Nextech Invest increases Relay Therapeutics stake by $6.1M, signaling institutional confidence in company's computational platform and clinical pipeline.
RVMDRVMDWRLAYXBIIBBinstitutional buyingbiotech investment
BenzingaBenzinga··Vandana Singh

Vertex's Kidney Drug Povetacicept Wins Pivotal Trial, Shares Jump 6%+

$VERX surges 6.3% after kidney drug povetacicept achieves Phase 3 trial success with 52% proteinuria reduction, positioning FDA approval by year-end.
VRTXIBBBBHFDA approvalclinical development
The Motley FoolThe Motley Fool··Jake Lerch

Boxer Capital Doubles Down on TNGX With $9.5M Stake as Biotech Stock Soars

Boxer Capital invests $9.5M in clinical-stage biotech $TNGX, raising stake to 21.09%, as stock surges 427% amid Gilead partnership momentum.
GILDTNGXIBBbiotechclinical-stage